-29.5%
MRNA vs ILMN
-45.4%
+15.9%
-93.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | ILMN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.3% | -4.5% | +5.7% | +4.0% |
| 7D | -13.8% | -4.2% | -9.6% | -11.9% |
| 30D | -17.7% | -25.1% | +7.4% | -3.9% |
| 3M | +14.3% | -2.1% | +16.4% | +12.1% |
| 6M | +336.0% | +41.6% | +294.4% | +263.8% |
| YTD | +575.9% | +53.0% | +522.9% | +441.5% |
| 1Y | +724.4% | +67.0% | +657.3% | +535.9% |
| 3Y | +160.8% | +118.7% | +42.1% | +67.4% |
| All | -29.5% | -45.4% | +15.9% | -15.9% |
Cumulative growth
Daily Returns
Daily percentage return beside ILMN.
Daily Out/Under-Performance
Portfolio return minus ILMN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ILMN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded ILMN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling